Non-Hodgkin's Lymphoma News & Features

A blood test that checks the level of tumor cells before and after cancer treatment could tell doctors within days or weeks, rather than months, whether the treatment has been effective, researchers report.

Immunotherapy is proving to be a powerful weapon against cancer. But is it the right choice for your non-Hodgkin's lymphoma? These are things to consider when making that decision.

All cancer treatments have side effects. That includes immunotherapy for non-Hodgkin's lymphoma. What can you expect, and what can you do about them?

CAR T therapy shows great promise for folks with primary mediastinal B-cell lymphoma, but it’s not for everyone. Learn how to know when it might be a good fit for you.

Immunotherapy is a cancer treatment that works with your immune system. It’s a common part of most treatment plans for many types of lymphoma.

Immunotherapy helps your body launch a deadly attack against cancer cells. But what if this potent new treatment doesn’t work for you?

Immunotherapy may be an option to help treat some types of immunotherapy. Find out what it’s like, including what the side effects may be, before you get started.

Common side effects from lymphoma immunotherapy and how to deal with them.

CAR T therapy for primary mediastinal B-cell lymphoma can be a lifesaver, but it does have its risks. Learn the side effects it may cause and how your doctor will keep them in check.

CAR T therapy for diffuse large B-cell lymphoma can be a lifesaver, but it does have its risks. Learn the side effects it may cause and how your doctor will keep them in check.

CAR T-cell therapy is an exciting choice that is available now for some people with diffuse large B-cell lymphoma. Is it right for you? We look at this cutting-edge treatment.

Learn what things your doctor will think about when deciding if CAR T-cell therapy might be right for you.

Find out more about the benefits of CAR T-cell therapy and the side effects it can cause.

The FDA has approved a first-of-its-kind treatment, called CAR T-cell therapy, to treat a type of leukemia in children and young adults.

Dasatinib prolonged survival in chronic myeloid leukemia patients, study says

Plus, there's no evidence of safety concerns linked to long-term use of the drug, researchers say

Over one-third of patients appeared disease-free 6 months after single treatment, report says

Tweaking T-cells from healthy donor allowed infants to reach remission, researchers report

Made by combining immune cells, cancer cells, it's kept some study patients in remission for nearly 5 years

Find out how you can decide if a clinical trial for non-Hodgkin's lymphoma is a good idea for you.

Find out when you should consider taking a "watch and wait" approach to a type of cancer called non-Hodgkin's lymphoma.

Get some simple strategies to handle the side effects of chemotherapy and radiation for non-Hodgkin's lymphoma, including fatigue, nausea, and hair loss.

The Nashville star shares his passion for advances in leukemia and lymphoma research

Early trial results termed 'fantastic step forward' in fight against non-Hodgkin lymphoma

Donors and recipients don't need to be a perfect match, researcher says